214 related articles for article (PubMed ID: 29963617)
1. Early Abrogation of Gelatinase Activity Extends the Time Window for tPA Thrombolysis after Embolic Focal Cerebral Ischemia in Mice.
Chen S; Chen Z; Cui J; McCrary ML; Song H; Mobashery S; Chang M; Gu Z
eNeuro; 2018; 5(3):. PubMed ID: 29963617
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of MMP-9 by a selective gelatinase inhibitor protects neurovasculature from embolic focal cerebral ischemia.
Cui J; Chen S; Zhang C; Meng F; Wu W; Hu R; Hadass O; Lehmidi T; Blair GJ; Lee M; Chang M; Mobashery S; Sun GY; Gu Z
Mol Neurodegener; 2012 May; 7():21. PubMed ID: 22587708
[TBL] [Abstract][Full Text] [Related]
3. Recombinant tissue plasminogen activator induces blood-brain barrier breakdown by a matrix metalloproteinase-9-independent pathway after transient focal cerebral ischemia in mouse.
Copin JC; Bengualid DJ; Da Silva RF; Kargiotis O; Schaller K; Gasche Y
Eur J Neurosci; 2011 Oct; 34(7):1085-92. PubMed ID: 21895804
[TBL] [Abstract][Full Text] [Related]
4. Transient brain hypothermia reduces the reperfusion injury of delayed tissue plasminogen activator and extends its therapeutic time window in a focal embolic stroke model.
Zarisfi M; Allahtavakoli F; Hassanipour M; Khaksari M; Rezazadeh H; Allahtavakoli M; Taghavi MM
Brain Res Bull; 2017 Sep; 134():85-90. PubMed ID: 28710023
[TBL] [Abstract][Full Text] [Related]
5. Release of Matrix Metalloproteinases-2 and 9 by S-Nitrosylated Caveolin-1 Contributes to Degradation of Extracellular Matrix in tPA-Treated Hypoxic Endothelial Cells.
Song H; Cheng Y; Bi G; Zhu Y; Jun W; Ma W; Wu H
PLoS One; 2016; 11(2):e0149269. PubMed ID: 26881424
[TBL] [Abstract][Full Text] [Related]
6. Bryostatin extends tPA time window to 6 h following middle cerebral artery occlusion in aged female rats.
Tan Z; Lucke-Wold BP; Logsdon AF; Turner RC; Tan C; Li X; Hongpaison J; Alkon DL; Simpkins JW; Rosen CL; Huber JD
Eur J Pharmacol; 2015 Oct; 764():404-412. PubMed ID: 26189021
[TBL] [Abstract][Full Text] [Related]
7. Normobaric hyperoxia reduces the neurovascular complications associated with delayed tissue plasminogen activator treatment in a rat model of focal cerebral ischemia.
Liu W; Hendren J; Qin XJ; Liu KJ
Stroke; 2009 Jul; 40(7):2526-31. PubMed ID: 19478225
[TBL] [Abstract][Full Text] [Related]
8. Whole body hypothermia extends tissue plasminogen activator treatment window in the rat model of embolic stroke.
Hassanipour M; Zarisfi M; Ehsani V; Allahtavakoli M
Life Sci; 2020 Sep; 256():117450. PubMed ID: 32087233
[TBL] [Abstract][Full Text] [Related]
9. Involvement of matrix metalloproteinase in thrombolysis-associated hemorrhagic transformation after embolic focal ischemia in rats.
Sumii T; Lo EH
Stroke; 2002 Mar; 33(3):831-6. PubMed ID: 11872911
[TBL] [Abstract][Full Text] [Related]
10. Lipoprotein receptor-mediated induction of matrix metalloproteinase by tissue plasminogen activator.
Wang X; Lee SR; Arai K; Lee SR; Tsuji K; Rebeck GW; Lo EH
Nat Med; 2003 Oct; 9(10):1313-7. PubMed ID: 12960961
[TBL] [Abstract][Full Text] [Related]
11. Progesterone attenuates hemorrhagic transformation after delayed tPA treatment in an experimental model of stroke in rats: involvement of the VEGF-MMP pathway.
Won S; Lee JH; Wali B; Stein DG; Sayeed I
J Cereb Blood Flow Metab; 2014 Jan; 34(1):72-80. PubMed ID: 24045404
[TBL] [Abstract][Full Text] [Related]
12. Extension of the thrombolytic time window with minocycline in experimental stroke.
Murata Y; Rosell A; Scannevin RH; Rhodes KJ; Wang X; Lo EH
Stroke; 2008 Dec; 39(12):3372-7. PubMed ID: 18927459
[TBL] [Abstract][Full Text] [Related]
13. Caveolin-1 mediates tissue plasminogen activator-induced MMP-9 up-regulation in cultured brain microvascular endothelial cells.
Jin X; Sun Y; Xu J; Liu W
J Neurochem; 2015 Mar; 132(6):724-30. PubMed ID: 25683686
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinase activation and blood-brain barrier breakdown following thrombolysis.
Kelly MA; Shuaib A; Todd KG
Exp Neurol; 2006 Jul; 200(1):38-49. PubMed ID: 16624294
[TBL] [Abstract][Full Text] [Related]
15. Tissue plasminogen activator promotes matrix metalloproteinase-9 upregulation after focal cerebral ischemia.
Tsuji K; Aoki T; Tejima E; Arai K; Lee SR; Atochin DN; Huang PL; Wang X; Montaner J; Lo EH
Stroke; 2005 Sep; 36(9):1954-9. PubMed ID: 16051896
[TBL] [Abstract][Full Text] [Related]
16. A highly specific inhibitor of matrix metalloproteinase-9 rescues laminin from proteolysis and neurons from apoptosis in transient focal cerebral ischemia.
Gu Z; Cui J; Brown S; Fridman R; Mobashery S; Strongin AY; Lipton SA
J Neurosci; 2005 Jul; 25(27):6401-8. PubMed ID: 16000631
[TBL] [Abstract][Full Text] [Related]
17. A Rho kinase (ROCK) inhibitor, fasudil, prevents matrix metalloproteinase-9-related hemorrhagic transformation in mice treated with tissue plasminogen activator.
Ishiguro M; Kawasaki K; Suzuki Y; Ishizuka F; Mishiro K; Egashira Y; Ikegaki I; Tsuruma K; Shimazawa M; Yoshimura S; Iwama T; Hara H
Neuroscience; 2012 Sep; 220():302-12. PubMed ID: 22710066
[TBL] [Abstract][Full Text] [Related]
18. Normobaric hyperoxia slows blood-brain barrier damage and expands the therapeutic time window for tissue-type plasminogen activator treatment in cerebral ischemia.
Liang J; Qi Z; Liu W; Wang P; Shi W; Dong W; Ji X; Luo Y; Liu KJ
Stroke; 2015 May; 46(5):1344-1351. PubMed ID: 25804925
[TBL] [Abstract][Full Text] [Related]
19. YangXueQingNaoWan attenuated blood brain barrier disruption after thrombolysis with tissue plasminogen activator in ischemia stroke.
Yao SQ; Ye Y; Li Q; Wang XY; Yan L; Huo XM; Pan CS; Fu Y; Liu J; Han JY
J Ethnopharmacol; 2024 Jan; 318(Pt B):117024. PubMed ID: 37572928
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size.
Romanic AM; White RF; Arleth AJ; Ohlstein EH; Barone FC
Stroke; 1998 May; 29(5):1020-30. PubMed ID: 9596253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]